Diabetes & Metabolism

Communities Weekly Rewind: Hope and Innovation in Nephrology

Months of efforts by ASN staff culminated on April 26, 2018, when ASN signed a Memorandum of Understanding with the Department of Health and Human Services to establish the Kidney Innovation Accelerator, KidneyX.

Newly Launched KidneyX Aims to Accelerate the Commercialization of Innovative Therapies in Kidney Care

ASN and the U.S. Department of Health and Human Services (HHS) have sent a clear signal in their desire to have new therapies in the kidney space through the signing of a Memorandum of Understanding establishing the Kidney Innovation Accelerator (KidneyX), a collaborative environment in which a community of researchers, innovators, and investors can participate.

NY Times: Diabetes in Pregnancy Raises Risk of Heart Disease

The women who had gestational diabetes were 20 times as likely as controls to develop Type 2 diabetes, consistent with previous studies, and the risk was highest in the first year after giving birth. In addition, these women were 2.8 times as likely to have heart disease, and nearly twice as likely to develop high blood pressure. The researchers controlled for age, body mass index, ethnicity, smoking and other variables.

FDA approved new type II diabetes drug

The new drug, developed by Merck & Co and Pfizer Inc., is an oral drug known generically as ertugliflozin and in the class of SGLT2 inhibitors, which work to expel excess glucose through urine.


The US Food and Drug Administration (FDA) approved the drug early this week. The drug is expected to be available for sale in early 2018.

Obesity and Kidney Disease: addressing hyperfiltration, diet, and caloric restriction

Public policy efforts to address the obesity epidemic must include the nephrology community because obesity among young adults substantially heightens lifetime risk of ESRD.  Strong attention to blood pressure control and dietary factors may help mitigate CKD risk and its progression.

Physician stress and burnout: The causes and potential solutions for nephrologists

At Kidney Week in New Orleans, I presented a session on the impact of growing stress and burnout in Nephrologists and how it might affect physician attitudes and behaviors toward patient care. The main point of my talk was to recognize how serious an issue physician dissatisfaction, stress, and burnout is, the causes and the barriers, and what can be done to help our physicians (and staff) better adjust to the pressures of today’s health care environment.


Let me explain.

Diabetes Prevention Program (MDPP) to be added to Medicare benefits in 2018

The Medicare Diabetes Prevention Program (MDPP) expanded model is a structured behavior change intervention that aims to prevent the onset of type 2 diabetes among Medicare beneficiaries with an indication of prediabetes.

ASN Foundation for Kidney Research Grants opened October 11

The ASN Foundation for Kidney Research (ASN Foundation) has now opened applications for its Career Development Grants, Clinician Educator Grant, and Research Fellowship program. The ASN Foundation funds clinical and basic research and provides grant support to ASN members at various points in their careers.

Comments and advice on how to read a journal’s rejection letter

Stephen Heard, an evolutionary ecologist and entomologist at the University of New Brunswick and previously faculty at the University of Iowa, recently published a short blog detailing how best to read and react to a rejection letter after submitting your work to a journal.

Click here if you’d like to read the full blog.

CDC Releases 2017 National CKD Fact Sheet

The 2017 National CKD Fact Sheet, to which ASN provided input, illustrates timely information, suggestions, and statistics on chronic kidney disease (CKD) in the United States.

Pages